SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice.

Molecular and Cellular Biology
Namit SharmaAndrew W B Craig

Abstract

Mast cells require KIT receptor tyrosine kinase signaling for development and survival. Here, we report that SH2 domain-containing phosphatase 2 (SHP2) signaling downstream of KIT is essential for mast cell survival and homeostasis in mice. Using a novel mouse model with shp2 deletion within mature mast cells (MC-shp2 knockout [KO]), we find that SHP2 is required for the homeostasis of connective tissue mast cells. Consistently with the loss of skin mast cells, MC-shp2 KO mice fail to mount a passive late-phase cutaneous anaphylaxis response. To better define the phenotype of shp2-deficient mast cells, we used an inducible shp2 knockout approach in bone marrow-derived mast cells (BMMCs) or cultured peritoneal mast cells and found that SHP2 promotes mast cell survival. We show that SHP2 promotes KIT signaling to extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase and downregulation of the proapoptotic protein Bim in BMMCs. Also, SHP2-deficient BMMCs failed to repopulate mast cells in mast cell-deficient mice. Silencing of Bim partially rescued survival defects in shp2-deficient BMMCs, consistent with the importance of a KIT → SHP2 → Ras/ERK pathway in suppressing Bim and promoting mast cell survival. Thu...Continue Reading

References

Aug 30, 1996·The Journal of Biological Chemistry·J M ArrandaleD U Rabin
May 15, 2002·Biochimica Et Biophysica Acta·Mauro SalviAntonio Toninello
Mar 5, 2003·The Journal of Cell Biology·Tsuyoshi MiyazakiRoland Baron
Jun 27, 2003·Trends in Biochemical Sciences·Benjamin G NeelLily Pao
Mar 17, 2004·The Journal of Experimental Medicine·Valter AgostiPeter Besmer
Apr 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yuki KimuraAlan Bernstein
Sep 21, 2004·Cellular and Molecular Life Sciences : CMLS·M SalviA Toninello
Nov 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric E ZhangGen-Sheng Feng
Aug 30, 2005·The American Journal of Pathology·Michele A GrimbaldestonStephen J Galli
Sep 1, 2005·Biochemical and Biophysical Research Communications·Robert Roskoski
Dec 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yojiro ArinobuKoichi Akashi
Mar 7, 2006·Developmental Cell·Wentian YangBenjamin G Neel
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Michael F Gurish, Joshua A Boyce
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Odile MalbecMarc Daëron
May 15, 2007·Immunological Reviews·George H Caughey
Nov 1, 2007·Transgenic Research·Julia ScholtenAxel Roers
Apr 12, 2008·The American Journal of Pathology·Maryla KrajewskaStan Krajewski
May 17, 2008·Nature Reviews. Immunology·Stephen J GalliMindy Tsai
Aug 8, 2008·Blood·Dean D Metcalfe
Mar 18, 2009·Immunological Reviews·Alasdair M Gilfillan, Juan Rivera
Jun 25, 2009·Current Opinion in Allergy and Clinical Immunology·Kayvan Hakim-RadMarcus Maurer
Sep 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Victor A McPhersonAndrew W B Craig
Oct 20, 2009·Biochimica Et Biophysica Acta·Icksoo LeeMaik Hüttemann
Apr 7, 2010·Cell Stem Cell·Christopher B FrancoStephen J Galli
Jul 30, 2011·Journal of Signal Transduction·Xia Liu, Cheng-Kui Qu

❮ Previous
Next ❯

Citations

Feb 14, 2013·Acta Neuropathologica·Sofie NelissenSven Hendrix
Oct 21, 2014·Future Medicinal Chemistry·Sam ButterworthAlastair J Barr
Oct 1, 2015·Expert Opinion on Therapeutic Targets·Nicole RainvilleDon M Wojchowski
Sep 6, 2015·European Journal of Medical Genetics·Mylène TajanArmelle Yart
May 21, 2013·Current Opinion in Immunology·Yacine BounabMarc Daëron
Nov 7, 2012·Trends in Immunology·Laurent L ReberStephen J Galli
May 6, 2015·European Journal of Pharmacology·Petr DraberToshiaki Kawakami
Mar 31, 2019·Nature Communications·Charlène NiogretGreta Guarda
Dec 23, 2014·Medical Science Monitor Basic Research·Hongquan DongYanning Qian
Aug 17, 2019·Disease Models & Mechanisms·Stephanie YoungAndrew W B Craig
Sep 26, 2015·Oncotarget·Ronit Vogt SionovZvi Granot
Apr 16, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Namit SharmaAndrew W B Craig
Jun 4, 2019·Frontiers in Immunology·Namit SharmaCatherine J McGlade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.